Regulation 2

“acute hospital service”, “ambulatory surgical centre service”, “community hospital service”, “contingency care service”, “nursing home service”, “outpatient medical service” and “outpatient renal dialysis service” have the meanings given by paragraph 2 of the First Schedule to the Act;

“collaborative practice agreement” means an agreement for and relating to the provision of a collaborative prescribing service by a collaborative prescribing practitioner for and on behalf of a licensee;

“collaborative prescribing practitioner” means a pharmacist or registered nurse who is approved by the credentialing committee under regulation 6(1)(a);

“collaborative prescribing service” means the following healthcare services provided by a licensee through a collaborative prescribing practitioner:

“credentialing committee” means the committee established under regulation 3(1)(d);

“health product” has the meaning given by section 2(1) of the Health Products Act 2007;

“healthcare professional” has the meaning given by regulation 2 of the Healthcare Services (General) Regulations 2021 (G.N. No. S 1035/2021);

“licensee” means a person who —

“medical practitioner‑in‑charge (CP)” means the individual appointed under regulation 3(1)(c);

“personnel”, in relation to a licensee, means any individual employed or engaged by the licensee to assist the licensee in providing a relevant licensable healthcare service;

“pharmacist” means an individual who is registered under the Pharmacists Registration Act 2007 and holds a valid practising certificate under that Act;

“registered nurse” means an individual who is a registered nurse within the meaning of the Nurses and Midwives Act 1999 and holds a valid practising certificate under that Act;

“relevant licensable healthcare service” means any of the following:

(da)a nursing home service;